Longwood Capital Partners »

Miragen Therapeutics shares owned by Longwood Capital Partners

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Longwood Capital Partners from 13F filings

Historical chart of Longwood Capital Partners investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Longwood Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Longwood Capital Partners

Quarter filed Position value Share count Share price at filing
2023-09-30 $3.4M 224k 15.34
2023-06-30 $5.3M 225k 23.79
2023-03-31 $4.3M 168k 25.44
2022-12-31 $12M 397k 29.21
2022-09-30 $7.4M 363k 20.51
2022-06-30 $2.7M 234k 11.57
2022-03-31 $6.3M 340k 18.49
2021-12-31 $6.3M 318k 19.77
2021-09-30 $2.2M 136k 16.45